Inhibikase Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.40

-0.01 (-0.41%)

As of Aug 15, 2:09 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,067.1% upside

Low Target $19.41

Average Target $28.01

High Target $39.32

Current Price $2.40

Current
$2.40

Target
$28.01

$19.41 $28.01 avg $39.32

Scenario Analysis

Bear Case

$19.41

708.8%

Low target

Base Case

$28.01

+1,067.1%

Avg target

Bull Case

$39.32

+1,538.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$2.53

-5.1% from high

52-Week Low

$1.33

+80.5% from low

Target vs 52W High

$28.01

+1,007.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%